VCAM1 and acute lymphoblastic leukemia: In MSC-leukemia co-cultures, VCAM-1 inhibitor could reestablish chemosensitivity to cytarabine and etoposide [90], indicating that targeting VLA-4/VCAM-1 may be a useful method to reduce stroma-mediated chemoresistance in B-ALL [91].